Brief: Tianjin Development Says Lisheng Pharmaceutical Entered Third Cmb Wealth Management Agreement
19/05/2020 16:26
May 19 (Reuters) - Tianjin Development Holdings Ltd
0882.HK :
* TIANJIN DEVELOPMENT-LISHENG PHARMACEUTICAL ENTERED THIRD
CMB
WEALTH MANAGEMENT AGREEMENT WITH CMB TO SUBSCRIBE FOR A WEALTH
MANAGEMENT FOR RMB50 MILLION
Further company coverage: 0882.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tianjin Development Holdings
See all newsHong Kong's Tianjin Development HY revenue on lower pharmaceutical, utilities sales
Brief: Tianjin Development Says Teng Fei Resigns As Chairman And Executive Director
Brief: Tianjin Development Says H1 2026 Net Profit Seen At RMB 73-83 Million For Tianjin Lisheng Pharmaceutical
Brief: Tianjin Development Says Lisheng Pharmaceutical Subscribes To Investment Products Totaling RMB180 Million
Brief: Tianjin Development Says Tianjin Lisheng Pharmaceutical QTRLY Operating Income RMB 332.28 Mln